OI
AMGN icon

Oakbrook Investments’s Amgen AMGN Stock Holding History

Oakbrook Investments’s Portfolio AMGN Stock Details AMGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		$232K Sell
1,142
-3,660
-76% -$799K 0.59% 61
2019
Q4 		$1.16M Sell
4,802
-153,690
-97% -$33.9M 0.24% 91
2019
Q3 		$30.7M Sell
158,492
-611
-0.4% -$117K 1.99% 14
2019
Q2 		$29.3M Sell
159,103
-9,128
-5% -$1.63M 1.76% 18
2019
Q1 		$32M Sell
168,231
-2,075
-1% -$396K 1.94% 16
2018
Q4 		$33.2M Sell
170,306
-1,120
-0.7% -$219K 2.25% 10
2018
Q3 		$35.5M Sell
171,426
-30,363
-15% -$5.98M 1.97% 9
2018
Q2 		$37.2M Buy
201,789
+18,965
+10% +$3.35M 2.35% 10
2018
Q1 		$31.2M Sell
182,824
-18,205
-9% -$3.34M 1.93% 15
2017
Q4 		$35M Sell
201,029
-2,360
-1% -$418K 2.22% 8
2017
Q3 		$37.9M Sell
203,389
-12,925
-6% -$2.29M 2.45% 3
2017
Q2 		$37.3M Sell
216,314
-2,845
-1% -$463K 2.47% 3
2017
Q1 		$36M Buy
219,159
+3,055
+1% +$508K 2.35% 4
2016
Q4 		$31.6M Buy
216,104
+921
+0.4% +$139K 2.07% 5
2016
Q3 		$35.9M Sell
215,183
-42,460
-16% -$7.18M 2.19% 2
2016
Q2 		$39.2M Buy
257,643
+49,955
+24% +$7.77M 2.17% 4
2016
Q1 		$31.1M Sell
207,688
-24,525
-11% -$3.64M 2% 6
2015
Q4 		$37.7M Buy
232,213
+30,995
+15% +$4.87M 2.41% 2
2015
Q3 		$27.8M Buy
201,218
+32,175
+19% +$5.07M 1.83% 8
2015
Q2 		$26M Sell
169,043
-4,250
-2% -$681K 1.58% 11
2015
Q1 		$27.7M Sell
173,293
-38,710
-18% -$6.1M 1.5% 11
2014
Q4 		$33.8M Buy
212,003
+39,410
+23% +$6.14M 1.82% 8
2014
Q3 		$24.2M Sell
172,593
-193,820
-53% -$25.3M 1.31% 13
2014
Q2 		$43.4M Buy
366,413
+247,146
+207% +$28.6M 1.31% 13
2014
Q1 		$14.7M Buy
119,267
+98,600
+477% +$12M 0.46% 53
2013
Q4 		$2.36M Sell
20,667
-213,448
-91% -$24.3M 0.07% 276
2013
Q3 		$26.2M Sell
234,115
-53,775
-19% -$5.83M 0.77% 32
2013
Q2 		$28.4M Buy
+287,890
New +$29.9M 0.82% 27

Other funds holding AMGN

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Oakbrook Investments's AMGN Position: Q1 2020 in Review

Oakbrook Investments reduced its Amgen (AMGN) stake by 76% in Q1 2020, selling an estimated $799K and leaving 1,142 shares worth $232K. The position accounts for 0.59% of the portfolio, ranked #61.

Oakbrook Investments first reported a position in AMGN in Q2 2013 and has held it in 28 quarters since. The position peaked at $43.4M in Q2 2014. 2,028 funds tracked by Wall St. Rank hold AMGN as of Q1 2020.

  • Oakbrook Investments held 1,142 shares of Amgen worth $232K as of Q1 2020.
  • Oakbrook Investments sold 3,660 Amgen shares in Q1 2020, an estimated $799K.
  • Amgen made up 0.59% of Oakbrook Investments's portfolio in Q1 2020, its #61 holding.
  • Oakbrook Investments first reported a position in Amgen in Q2 2013 and has held it in 28 quarters since.
  • Oakbrook Investments's Amgen position peaked at $43.4M in Q2 2014.
  • 2,028 funds tracked by Wall St. Rank held Amgen as of Q1 2020.

Based on Oakbrook Investments's 13F filing for Q1 2020, filed 22 Apr 2020.